Are Glucocorticoids Associated With Worse Survival Among Patients With Rheumatoid Arthritis and Lung Cancer Treated With Immune Checkpoint Inhibitors?
Glucocorticoids, at the dosages used to treat ICI-treated patients with RA and mNSCLC, had a negligible effect on survival in the 91 days after ICI initiation.
Authors
- Jeffrey R. Curtis (ORCID: https://orcid.org/0000-0002-8907-8976)
- Deanna Jannat‐Khah (ORCID: https://orcid.org/0000-0002-1091-379X)
- Fenglong Xie (ORCID: https://orcid.org/0000-0002-7365-4801)
- Anne R. Bass (ORCID: https://orcid.org/0000-0002-3225-8351)
- Ashish Saxena (ORCID: https://orcid.org/0000-0003-3353-129X)
Institutions
- Hospital for Special Surgery (US)
- Foundation for Advancement of International Medical Education and Research (US)
- University of Advancing Technology (US)
- Cornell University (US)
- University of Alabama at Birmingham (US)
Publication Details
- Journal
- Arthritis & Rheumatology
- Published
- 2025-11-25
- DOI
- https://doi.org/10.1002/art.43445
- Citations
- 1
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 1.67
Funders
- Hospital for Special Surgery
- National Institute of Arthritis and Musculoskeletal and Skin Diseases